Demant A/S header image

Demant A/S

DEMANT

Equity

ISIN DK0060738599 / Valor 32651962

Nasdaq Copenhagen Equities (2025-10-20)
DKK 239.80+1.01%

Demant A/S
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Demant A/S is a prominent global player in the hearing healthcare industry, with a history dating back to 1904. The company is headquartered in Denmark and operates in over 130 countries, employing more than 22,000 people worldwide. Demant specializes in providing a comprehensive range of hearing solutions, including hearing aids, hearing care services, and diagnostic equipment. The company is known for its innovative approach to improving hearing health, leveraging advanced technologies to enhance the quality of life for individuals with hearing impairments. Demant A/S is publicly traded on Nasdaq Copenhagen and is significantly influenced by the William Demant Foundation, which holds the majority of its shares.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (25.09.2025):

Demant A/S has released its financial results for the first half of 2025, demonstrating a steady revenue growth of 2% compared to the same period in the previous year. However, the company faced a decline in operating profit and earnings per share, reflecting challenges in certain market segments and increased investments.

Revenue Growth

Demant A/S reported a revenue of DKK 11,253 million for H1 2025, marking a 2% increase from DKK 11,087 million in H1 2024. This growth was primarily driven by strong performance in Europe and strategic acquisitions in the Hearing Care sector.

Operating Profit Decline

The operating profit before special items decreased by 11% to DKK 1,849 million in H1 2025, down from DKK 2,068 million in the previous year. This decline was attributed to unfavorable market developments in North America and increased operational expenses.

Earnings Per Share

Earnings per share (EPS) for continuing operations decreased to DKK 5.28 in H1 2025 from DKK 5.47 in H1 2024, reflecting the downturn in operating profit and ongoing investments in growth initiatives.

Free Cash Flow

Free cash flow (FCF) saw a slight reduction to DKK 1,126 million in H1 2025 compared to DKK 1,157 million in H1 2024. This change is largely due to increased capital expenditures and strategic investments in property, plant, and equipment.

Profit After Tax

Profit after tax for continuing operations stood at DKK 1,130 million in H1 2025, down from DKK 1,354 million in H1 2024. This decrease highlights the impact of lower operating margins and higher financial costs.

Sustainability Initiatives

Demant A/S continued its commitment to sustainability with Scope 1 and 2 greenhouse gas emissions totaling 13,228 tonnes of CO2e in H1 2025. The company maintained a renewable electricity share of 55%, up from 38% in the previous year.

Summarized from source with an LLMView Source

Key figures

-10.9%1Y
16.6%3Y
11.8%5Y

Performance

30.6%1Y
33.8%3Y
35.9%5Y

Volatility

Market cap

7591 M

Market cap (USD)

Daily traded volume (Shares)

295,066

Daily traded volume (Shares)

1 day high/low

267.8 / 261.4

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

iRhythm Technologies Inc
iRhythm Technologies Inc iRhythm Technologies Inc Valor: 34117792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.25%USD 182.25
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.67%CHF 59.92
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.87%CHF 87.68
Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 461641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.52%USD 55.74
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.22%CHF 149.40
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.38%CHF 12.95
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.26%USD 193.72
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 80.10
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.04%CHF 6.17
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 0.82